Carotid Revascularization in Asymptomatic Patients after Renal Transplantation

Isibor Arhuidese, Rebecca Craig-Schapiro, Tammam Obeid, Besma Nejim, Caitlin Hicks, Mahmoud B. Malas

Research output: Contribution to journalArticle

Abstract

Background: In multiple studies, chronic renal insufficiency has been associated with increased risk of periprocedural stroke, cardiac complications, and death following carotid revascularization. Renal transplantation has been shown to reduce cardiovascular risk and improve survival; outcomes after carotid revascularization in renal transplant patients however are unknown. In this study, we evaluate periprocedural and long-term risks after carotid endarterectomy (CEA) and carotid artery stenting (CAS) in a cohort of renal transplant patients. Methods: We studied all renal transplant patients in the United States Renal Data System who underwent CEA or CAS between January 2006 and December 2011. Patient outcomes were determined by linking with the Medicare database. Propensity score matched logistic and cox regression analyses were employed to evaluate perioperative stroke, myocardial infarction (MI), and death and long-term stroke and death. Results: Of the 462 revascularizations for asymptomatic carotid artery stenosis between 2006 and 2011, 387 (84%) were CEA and 75 (16%) were CAS. The 2 groups did not differ in age, gender, sex, race, or baseline medical characteristics. There was no significant difference in perioperative stroke, MI, or death rates in the CEA cohort (4.7%, 4.4%, and 1.3%, respectively) compared with the CAS cohort (5.3%, 2.7%, and 4.0%, respectively). Stroke-free survival for CEA versus CAS was 93% vs. 92% at 1 year, 90% vs. 87% at 2 years, 88% vs. 87% at 3 years, and 84% vs. 82% at 4 years (P = 0.81). Overall patient survival for CEA versus CAS was 89% vs. 88% at 1 year, 77% vs. 75% at 2 years, 66% for both at 3 years, and 53% vs. 48% at 4 years (P = 0.68). In propensity score matched Cox regression analysis, there was no difference in risk of perioperative stroke or MI or in long-term stroke or death for CAS compared with CEA. Conclusions: This is the first study to evaluate outcomes following CEA and CAS in renal transplant patients. The incidence of perioperative complications in this group is higher than the maximum recommended by the Society of Vascular Surgery, and the benefits of revascularization may be outweighed by the excess periprocedural morbidity and reduced life expectancy of these patients.

Original languageEnglish (US)
JournalAnnals of Vascular Surgery
DOIs
StateAccepted/In press - Apr 20 2016

Fingerprint

Carotid Endarterectomy
Carotid Arteries
Kidney Transplantation
Stroke
Kidney
Transplants
Propensity Score
Myocardial Infarction
Survival
Regression Analysis
Carotid Stenosis
Medicare
Life Expectancy
Chronic Renal Insufficiency
Information Systems
Blood Vessels
Logistic Models
Databases
Morbidity
Mortality

ASJC Scopus subject areas

  • Surgery
  • Cardiology and Cardiovascular Medicine

Cite this

Carotid Revascularization in Asymptomatic Patients after Renal Transplantation. / Arhuidese, Isibor; Craig-Schapiro, Rebecca; Obeid, Tammam; Nejim, Besma; Hicks, Caitlin; Malas, Mahmoud B.

In: Annals of Vascular Surgery, 20.04.2016.

Research output: Contribution to journalArticle

Arhuidese, Isibor ; Craig-Schapiro, Rebecca ; Obeid, Tammam ; Nejim, Besma ; Hicks, Caitlin ; Malas, Mahmoud B. / Carotid Revascularization in Asymptomatic Patients after Renal Transplantation. In: Annals of Vascular Surgery. 2016.
@article{7d41a9e1a75948d795c0a63717a80936,
title = "Carotid Revascularization in Asymptomatic Patients after Renal Transplantation",
abstract = "Background: In multiple studies, chronic renal insufficiency has been associated with increased risk of periprocedural stroke, cardiac complications, and death following carotid revascularization. Renal transplantation has been shown to reduce cardiovascular risk and improve survival; outcomes after carotid revascularization in renal transplant patients however are unknown. In this study, we evaluate periprocedural and long-term risks after carotid endarterectomy (CEA) and carotid artery stenting (CAS) in a cohort of renal transplant patients. Methods: We studied all renal transplant patients in the United States Renal Data System who underwent CEA or CAS between January 2006 and December 2011. Patient outcomes were determined by linking with the Medicare database. Propensity score matched logistic and cox regression analyses were employed to evaluate perioperative stroke, myocardial infarction (MI), and death and long-term stroke and death. Results: Of the 462 revascularizations for asymptomatic carotid artery stenosis between 2006 and 2011, 387 (84{\%}) were CEA and 75 (16{\%}) were CAS. The 2 groups did not differ in age, gender, sex, race, or baseline medical characteristics. There was no significant difference in perioperative stroke, MI, or death rates in the CEA cohort (4.7{\%}, 4.4{\%}, and 1.3{\%}, respectively) compared with the CAS cohort (5.3{\%}, 2.7{\%}, and 4.0{\%}, respectively). Stroke-free survival for CEA versus CAS was 93{\%} vs. 92{\%} at 1 year, 90{\%} vs. 87{\%} at 2 years, 88{\%} vs. 87{\%} at 3 years, and 84{\%} vs. 82{\%} at 4 years (P = 0.81). Overall patient survival for CEA versus CAS was 89{\%} vs. 88{\%} at 1 year, 77{\%} vs. 75{\%} at 2 years, 66{\%} for both at 3 years, and 53{\%} vs. 48{\%} at 4 years (P = 0.68). In propensity score matched Cox regression analysis, there was no difference in risk of perioperative stroke or MI or in long-term stroke or death for CAS compared with CEA. Conclusions: This is the first study to evaluate outcomes following CEA and CAS in renal transplant patients. The incidence of perioperative complications in this group is higher than the maximum recommended by the Society of Vascular Surgery, and the benefits of revascularization may be outweighed by the excess periprocedural morbidity and reduced life expectancy of these patients.",
author = "Isibor Arhuidese and Rebecca Craig-Schapiro and Tammam Obeid and Besma Nejim and Caitlin Hicks and Malas, {Mahmoud B.}",
year = "2016",
month = "4",
day = "20",
doi = "10.1016/j.avsg.2016.06.008",
language = "English (US)",
journal = "Annals of Vascular Surgery",
issn = "0890-5096",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Carotid Revascularization in Asymptomatic Patients after Renal Transplantation

AU - Arhuidese, Isibor

AU - Craig-Schapiro, Rebecca

AU - Obeid, Tammam

AU - Nejim, Besma

AU - Hicks, Caitlin

AU - Malas, Mahmoud B.

PY - 2016/4/20

Y1 - 2016/4/20

N2 - Background: In multiple studies, chronic renal insufficiency has been associated with increased risk of periprocedural stroke, cardiac complications, and death following carotid revascularization. Renal transplantation has been shown to reduce cardiovascular risk and improve survival; outcomes after carotid revascularization in renal transplant patients however are unknown. In this study, we evaluate periprocedural and long-term risks after carotid endarterectomy (CEA) and carotid artery stenting (CAS) in a cohort of renal transplant patients. Methods: We studied all renal transplant patients in the United States Renal Data System who underwent CEA or CAS between January 2006 and December 2011. Patient outcomes were determined by linking with the Medicare database. Propensity score matched logistic and cox regression analyses were employed to evaluate perioperative stroke, myocardial infarction (MI), and death and long-term stroke and death. Results: Of the 462 revascularizations for asymptomatic carotid artery stenosis between 2006 and 2011, 387 (84%) were CEA and 75 (16%) were CAS. The 2 groups did not differ in age, gender, sex, race, or baseline medical characteristics. There was no significant difference in perioperative stroke, MI, or death rates in the CEA cohort (4.7%, 4.4%, and 1.3%, respectively) compared with the CAS cohort (5.3%, 2.7%, and 4.0%, respectively). Stroke-free survival for CEA versus CAS was 93% vs. 92% at 1 year, 90% vs. 87% at 2 years, 88% vs. 87% at 3 years, and 84% vs. 82% at 4 years (P = 0.81). Overall patient survival for CEA versus CAS was 89% vs. 88% at 1 year, 77% vs. 75% at 2 years, 66% for both at 3 years, and 53% vs. 48% at 4 years (P = 0.68). In propensity score matched Cox regression analysis, there was no difference in risk of perioperative stroke or MI or in long-term stroke or death for CAS compared with CEA. Conclusions: This is the first study to evaluate outcomes following CEA and CAS in renal transplant patients. The incidence of perioperative complications in this group is higher than the maximum recommended by the Society of Vascular Surgery, and the benefits of revascularization may be outweighed by the excess periprocedural morbidity and reduced life expectancy of these patients.

AB - Background: In multiple studies, chronic renal insufficiency has been associated with increased risk of periprocedural stroke, cardiac complications, and death following carotid revascularization. Renal transplantation has been shown to reduce cardiovascular risk and improve survival; outcomes after carotid revascularization in renal transplant patients however are unknown. In this study, we evaluate periprocedural and long-term risks after carotid endarterectomy (CEA) and carotid artery stenting (CAS) in a cohort of renal transplant patients. Methods: We studied all renal transplant patients in the United States Renal Data System who underwent CEA or CAS between January 2006 and December 2011. Patient outcomes were determined by linking with the Medicare database. Propensity score matched logistic and cox regression analyses were employed to evaluate perioperative stroke, myocardial infarction (MI), and death and long-term stroke and death. Results: Of the 462 revascularizations for asymptomatic carotid artery stenosis between 2006 and 2011, 387 (84%) were CEA and 75 (16%) were CAS. The 2 groups did not differ in age, gender, sex, race, or baseline medical characteristics. There was no significant difference in perioperative stroke, MI, or death rates in the CEA cohort (4.7%, 4.4%, and 1.3%, respectively) compared with the CAS cohort (5.3%, 2.7%, and 4.0%, respectively). Stroke-free survival for CEA versus CAS was 93% vs. 92% at 1 year, 90% vs. 87% at 2 years, 88% vs. 87% at 3 years, and 84% vs. 82% at 4 years (P = 0.81). Overall patient survival for CEA versus CAS was 89% vs. 88% at 1 year, 77% vs. 75% at 2 years, 66% for both at 3 years, and 53% vs. 48% at 4 years (P = 0.68). In propensity score matched Cox regression analysis, there was no difference in risk of perioperative stroke or MI or in long-term stroke or death for CAS compared with CEA. Conclusions: This is the first study to evaluate outcomes following CEA and CAS in renal transplant patients. The incidence of perioperative complications in this group is higher than the maximum recommended by the Society of Vascular Surgery, and the benefits of revascularization may be outweighed by the excess periprocedural morbidity and reduced life expectancy of these patients.

UR - http://www.scopus.com/inward/record.url?scp=84995403824&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84995403824&partnerID=8YFLogxK

U2 - 10.1016/j.avsg.2016.06.008

DO - 10.1016/j.avsg.2016.06.008

M3 - Article

JO - Annals of Vascular Surgery

JF - Annals of Vascular Surgery

SN - 0890-5096

ER -